Zang DY - Search Results

1

Foretinib Inhibits Cancer Stemness and Gastric Cancer Cell Proliferation by Decreasing CD44 and c-MET Signaling.

Sohn SH, Kim B, Sul HJ, Choi BY, Kim HS, Zang DY. Sohn SH, et al. Among authors: zang dy. Onco Targets Ther. 2020 Feb 3;13:1027-1035. doi: 10.2147/OTT.S226951. eCollection 2020. Onco Targets Ther. 2020. PMID: 32099405 Free PMC article.

2

Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study.

Kim JH, Kim HS, Kwon JH, Park S, Kim HY, Jung JY, Kim HJ, Song HH, Lee GW, Lee SI, Gong SJ, Lee JA, Kim KJ, Zang DY. Kim JH, et al. Among authors: zang dy. Lung Cancer. 2009 Mar;63(3):405-9. doi: 10.1016/j.lungcan.2008.06.002. Epub 2008 Jul 14. Lung Cancer. 2009. PMID: 18621432

3

Bilateral subdural hemorrhage as a possible adverse event of gefitinib in a patient with non-small cell lung cancer.

Kim JH, Kim HS, Choi JS, Lee KM, Shin YC, Ahn BM, Choi DR, Kwon JH, Park S, Kim HY, Jung JY, Kim HJ, Song HH, Zang DY. Kim JH, et al. Among authors: zang dy. Lung Cancer. 2009 Apr;64(1):121-3. doi: 10.1016/j.lungcan.2008.10.007. Epub 2008 Nov 20. Lung Cancer. 2009. PMID: 19022521

4

Dose-finding study of docetaxel, oxaliplatin, and S-1 for patients with advanced gastric cancer.

Zang DY, Yang DH, Kim MJ, Jang KM, Hwang SW, Yoo KS, Han T, Kim HY, Kim HJ, Kwon JH, Song HH, Park S, Jung JY, Kim HS, Kim JH. Zang DY, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):877-83. doi: 10.1007/s00280-009-0936-6. Epub 2009 Feb 4. Cancer Chemother Pharmacol. 2009. PMID: 19190908

5

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer.

Kwon JH, Kim JH, Lee JA, Shin HC, Kim HJ, Song HH, Jung JY, Kim HY, Choi DR, Kim HS, Park YI, Zang DY. Kwon JH, et al. Among authors: zang dy. Cancer Chemother Pharmacol. 2010 Oct;66(5):889-97. doi: 10.1007/s00280-009-1235-y. Epub 2010 Jan 21. Cancer Chemother Pharmacol. 2010. PMID: 20091311 Clinical Trial.

6

A phase II study of pemetrexed and carboplatin as a salvage therapy for platinum-pretreated patients with non-small cell lung cancer.

Kim HS, Lee GW, Kim JH, Kim HY, Kwon JH, Song HH, Kim HJ, Jung JY, Jang G, Choi DR, Park SM, Shin TR, Lee HS, Zang DY. Kim HS, et al. Among authors: zang dy. Lung Cancer. 2010 Oct;70(1):71-6. doi: 10.1016/j.lungcan.2009.12.015. Epub 2010 Jan 21. Lung Cancer. 2010. PMID: 20096475 Clinical Trial.

7

Oxaliplatin, 5-fluorouracil and leucovorin (modified FOLFOX-6) as first-line chemotherapy for advanced gastric cancer patients with poor performance status.

Kim HS, Kim JH, Kim HJ, Jang HJ, Kim JB, Kim JW, Jung SY, Kim BC, Yang DH, Park S, Kim KJ, Lee SI, Zang DY. Kim HS, et al. Among authors: zang dy. Oncol Lett. 2012 Feb;3(2):425-428. doi: 10.3892/ol.2011.496. Epub 2011 Nov 25. Oncol Lett. 2012. PMID: 22740925 Free PMC article.

8

A phase II study of mitomycin-C and S-1 as third-line chemotherapy in patients with advanced colorectal cancer.

Kim JH, Kim HS, Choi DR, Jang G, Kwon JH, Kim HY, Jung JY, Kim HJ, Song HH, Shin YH, Jung SY, Kim BC, Zang DY. Kim JH, et al. Among authors: zang dy. Oncol Lett. 2011 Nov;2(6):1253-1256. doi: 10.3892/ol.2011.367. Epub 2011 Jul 27. Oncol Lett. 2011. PMID: 22848297 Free PMC article.

9

Influence of enzyme and transporter polymorphisms on trough imatinib concentration and clinical response in chronic myeloid leukemia patients.

Seong SJ, Lim M, Sohn SK, Moon JH, Oh SJ, Kim BS, Ryoo HM, Chung JS, Joo YD, Bang SM, Jung CW, Kim DH, Park SY, Yoon SS, Kim I, Lee HG, Won JH, Min YH, Cheong JW, Park JS, Eom KS, Hyun MS, Kim MK, Kim H, Park MR, Park J, Kim CS, Kim HJ, Kim YK, Park EK, Zang DY, Jo DY, Lee HW, Yoon YR. Seong SJ, et al. Among authors: zang dy. Ann Oncol. 2013 Mar;24(3):756-60. doi: 10.1093/annonc/mds532. Epub 2012 Oct 31. Ann Oncol. 2013. PMID: 23117072 Free article.

10

Predictors of high score patient-reported barriers to controlling cancer pain: a preliminary report.

Kwon JH, Oh SY, Chisholm G, Lee JA, Lee JJ, Park KW, Nam SH, Song HH, Lee K, Zang DY, Kim HY, Choi DR, Kim HJ, Kim JH, Jung JY, Jang G, Kim HS, Won JY, Bruera E. Kwon JH, et al. Among authors: zang dy. Support Care Cancer. 2013 Apr;21(4):1175-83. doi: 10.1007/s00520-012-1646-x. Epub 2012 Nov 15. Support Care Cancer. 2013. PMID: 23151648 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page